This new complaint, along with a few others, centers on vision loss, alleging that Novo Nordisk failed to adequately warn users about the risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition characterized by reduced blood flow to the optic nerve
If you take glucose lowering medications, consult your clinician before starting and monitor closely
Most are mild to moderate and tend to diminish over time as your body adjusts to the medication
At the same time, MKLP2 activates ARK5 or ARK5 inhibits PP1 activity, thereby decreasing GSK3 activity, increasing nuclear translocation of Nrf2 and inhibiting ferroptosis [120]
This structure reduces duplication, allows consistent rulings on key questions, and often moves cases forward more efficiently
I know that this was bound to happendata, cookies, whatever the fuckbut still, its jarring